By Peplyte 1 month ago
ALL ARTICLES AND PRODUCT INFORMATION PROVIDED ON THIS WEBSITE ARE SOLELY FOR INFORMATION DISSEMINATION AND EDUCATIONAL PURPOSES.
The products provided on this website are intended exclusively for in vitro research. In vitro research (Latin: *in glass*, meaning in glassware) is conducted outside the human body. These products are not pharmaceuticals, have not been approved by the U.S. Food and Drug Administration (FDA), and must not be used to prevent, treat, or cure any medical condition, disease, or ailment. It is strictly prohibited by law to introduce these products into the human or animal body in any form.
1. Overview
Slu-PP-332, a synthetic estrogen receptor-related orphan receptor (ERR) agonist, can have positive effects on human health in multiple ways. From a chemical structural perspective, it belongs to a specific class of small-molecule compounds that can precisely bind to ERR receptors, thereby activating a series of physiological responses. Unlike traditional drugs or methods for regulating bodily functions, Slu-PP-332 exerts physiological regulation by targeting the relatively novel ERR receptor.
Figure 1 The chemical structure of Slu-PP-332.
2. Mechanism of Action
Energy Metabolism Regulation: Slu-PP-332 exhibits significant regulatory effects on energy metabolism. It activates the ERR receptor, enhancing energy expenditure. At the cellular level, it increases mitochondrial function and improves cellular respiratory efficiency, enabling cells to convert nutrients into energy more efficiently. In skeletal muscle cells, Slu-PP-332 induces the expression of related genes, promoting fatty acid oxidation, allowing fat to be utilized more fully as an energy source and reducing fat accumulation. These effects mimic the body’s energy metabolism during exercise, enabling the body to maintain a high level of energy expenditure even at rest, which helps maintain a healthy weight and improve overall metabolic status.
Improved skeletal muscle function: In terms of skeletal muscle, Slu-PP-332 demonstrates positive effects. It can activate the acute aerobic exercise genetic program, which depends on the ERRα receptor. Studies have shown that after administering Slu-PP-332 to mice, there was an increase in type IIa oxidative skeletal muscle fibers, which enhances muscle endurance. Type IIa fibers have higher oxidative capacity, enabling more efficient use of oxygen to produce energy, thereby prolonging muscle activity duration. For humans, this suggests that Slu-PP-332 may help improve exercise endurance, potentially benefiting both athletes seeking to enhance performance and individuals aiming to enhance daily physical capabilities. Its enhancement of skeletal muscle mitochondrial function may also help reduce muscle fatigue and accelerate post-exercise recovery.
Cardiac function maintenance: Estrogen receptor-related orphan receptors ERRα and ERRγ are key regulators of cardiac metabolism. Mice lacking ERRα and ERRγ develop fatal cardiomyopathy and heart failure. As an effective ERR agonist, Slu-PP-332 plays a crucial role in maintaining cardiac function. Researchers induced heart failure in adult male mice via aortic coarctation (TAC) and then administered Slu-PP-332 for treatment. Slu-PP-332 treatment significantly improved the ejection fraction of the mice, an important indicator of cardiac pumping function, indicating enhanced cardiac contractility. It also improved mitochondrial ultrastructure, reduced cardiac fibrosis, and normalized the abnormal expression of related genes. These changes collectively contribute to maintaining the heart’s normal structure and function. Slu-PP-332’s improvement in cardiac function is attributed to its enhancement of mitochondrial function and regulation of fatty acid metabolism pathways, offering a new therapeutic approach for heart failure.
3. Applications
Sports Medicine Field: In sports medicine, Slu-PP-332 holds great potential for application. For athletes, it can serve as a novel performance-enhancing agent. By improving exercise endurance and reducing muscle fatigue, athletes can perform more effectively during training and competitions. Long-distance runners may experience extended exercise endurance limits and improved competition performance after use. For general fitness enthusiasts, Slu-PP-332 can help them achieve a more efficient state of energy metabolism during exercise, improve exercise effectiveness, reduce post-exercise muscle soreness and other discomfort, and promote physical recovery, enabling them to participate more actively in exercise and training. For those unable to engage in high-intensity exercise due to declining physical function, such as the elderly or patients with certain chronic diseases, Slu-PP-332 improves muscle function and energy metabolism, enabling them to engage in moderate exercise and thereby enhance their quality of life.
Metabolic disease treatment: In the treatment of metabolic diseases, Slu-PP-332 also demonstrates significant potential. Taking obesity as an example, it enhances energy expenditure and reduces fat accumulation, offering new treatment options for obese patients. Preclinical studies indicate that in diet-induced obese mice or ob/ob mouse models, administration of Slu-PP-332 effectively reduces body weight and improves insulin sensitivity. This is also significant for patients with type 2 diabetes, as insulin resistance is one of the key pathophysiological mechanisms of type 2 diabetes. Slu-PP-332 improves insulin sensitivity, thereby aiding in better control of blood glucose levels. For individuals with metabolic syndrome, Slu-PP-332 can comprehensively improve multiple metabolic disorders, such as dyslipidemia and hypertension, thereby reducing the risk of complications such as cardiovascular disease.
4. Conclusion
Heart disease prevention and treatment: Given Slu-PP-332’s positive effects on cardiac function, it holds significant application value in the field of heart disease prevention and treatment. For heart failure patients, current treatment options are limited, but Slu-PP-332 improves cardiac function by enhancing mitochondrial function and regulating fatty acid metabolism, providing a new drug target for heart failure treatment. For populations at risk of heart disease, such as those with hypertension or coronary heart disease, Slu-PP-332 may play a preventive role by maintaining normal cardiac metabolism and function, thereby reducing the risk of heart disease. In summary, Slu-PP-332, as a compound with a unique mechanism of action, can improve bodily functions.
Sources
[1] Nasri H. New hopes on “SLU-PP-332” as an effective agent for weight loss with indirect kidney protection efficacy; a nephrology point of view[J]. Journal of Renal Endocrinology, 2024. https://api.semanticscholar.org/CorpusID:267189187.
[2] Billon C, Sitaula S, Banerjee S, et al. A Synthetic ERR$alpha$ Agonist Induces an Acute Aerobic Exercise Response and Enhances Exercise Capacity[J]. Biorxiv, 2022. https://api.semanticscholar.org/CorpusID:252819965.
[3] Xu W, Billon C, Li H, et al. Abstract 9682: The Cardiac Protective Effects of Novel Synthetic Pan-Estrogen Related Receptor Agonists Slu-pp-332 and Slu-pp-915[J]. Circulation, 2021,144.DOI:10.1161/circ.144.suppl_1.9682.
Product available for research use only:
Tissue regeneration is vital for health and recovery. Injury or stress can disrupt this process.
BPC-157, TB-500, and GHK-Cu are peptides that support tissue healing. Together, they offer powerful synergistic effects.
In this article, we will explore how these peptides work together for faster recovery and overall health. Learn more about our products at Peplyte.
BPC-157, a peptide originally isolated from gastric juice, is renowned for its powerful healing properties. It has shown remarkable potential in tissue repair by stimulating blood vessel formation (angiogenesis), reducing inflammation, and promoting collagen production. This peptide plays a crucial role in the regeneration of various tissues, including tendons, muscles, nerves, and bones, supporting overall tissue health and recovery.
BPC-157 works by stimulating the migration of endothelial cells to damaged tissues, aiding in the formation of new blood vessels, and improving oxygen delivery to the affected area. This enhanced blood supply accelerates healing. Additionally, BPC-157 supports fibroblasts, which are responsible for collagen synthesis, ensuring that tissue regeneration occurs efficiently and with minimal scarring.
While BPC-157 offers essential support for tissue repair and vascular regeneration, its healing capabilities are significantly enhanced when combined with other peptides like TB-500 and GHK-Cu. These peptides work together, amplifying the regenerative process by targeting various aspects of tissue recovery, ensuring comprehensive healing.
TB-500, a synthetic version of Thymosin Beta-4 (Tβ4), is widely recognized for its ability to enhance cell migration, reduce inflammation, and promote tissue repair. Its unique mechanism helps repair cells travel efficiently to the site of injury, boosting the overall healing process.
TB-500 binds to actin, a protein essential for cell movement, allowing repair cells to migrate rapidly to injured tissues. This action is particularly beneficial in tendon, ligament, and muscle injuries, where the movement of repair cells is vital for rebuilding damaged tissue structures. It significantly speeds up the healing process.
Similar to BPC-157, TB-500 also stimulates angiogenesis by increasing vascular endothelial growth factor (VEGF) expression. This encourages the formation of new blood vessels, ensuring that oxygen and nutrients reach damaged tissues more effectively. By enhancing blood supply to the injured area, TB-500 aids in faster recovery and reduces healing time.
When used together with BPC-157 and GHK-Cu, TB-500 accelerates tissue healing by ensuring that the right cells are delivered efficiently to the injury site. Its effects on angiogenesis complement BPC-157’s vascular support and GHK-Cu’s collagen production, optimizing the overall regeneration process.
GHK-Cu, a naturally occurring peptide that binds copper, plays an essential role in tissue repair, particularly in wound healing, collagen production, and the regeneration of skin, cartilage, and other tissues. It has also shown promise in reversing signs of aging by promoting cellular renewal and repair.
One of the primary roles of GHK-Cu is to stimulate collagen and elastin production. These proteins are essential for skin elasticity and tissue strength. GHK-Cu activates genes responsible for synthesizing these proteins, which is crucial for restoring the structural integrity of tissues during the healing process. It significantly aids in the regeneration of damaged skin and connective tissues.
GHK-Cu also possesses strong anti-inflammatory and antioxidant properties. It reduces the levels of pro-inflammatory cytokines at the injury site, helping control inflammation. By reducing oxidative stress, GHK-Cu protects cells from damage and ensures the healing process proceeds efficiently and without interruption.
When used in combination with BPC-157 and TB-500, GHK-Cu plays a pivotal role in enhancing collagen production and improving the overall integrity of the tissue. It also ensures the extracellular matrix, which supports cell growth, is properly structured. This synergy contributes to better tissue quality and more effective repair, accelerating the healing process and improving recovery outcomes.
By working together, BPC-157, TB-500, and GHK-Cu create a powerful synergy that maximizes tissue regeneration and recovery, supporting the healing process from multiple angles. Whether used for muscle, skin, or connective tissue repair, the combined action of these peptides offers comprehensive, accelerated healing.
|
Peptide |
Key Benefits |
Main Applications |
Mechanism of Action |
|
BPC-157 |
Promotes angiogenesis, reduces inflammation |
Musculoskeletal injuries, gastrointestinal healing |
Stimulates blood vessel formation and collagen synthesis |
|
TB-500 |
Enhances cell migration, reduces fibrosis |
Muscle, tendon, and ligament repair, skin healing |
Increases cell movement to injured areas, enhances wound healing |
|
GHK-Cu |
Boosts collagen production, improves skin elasticity |
Skin regeneration, connective tissue repair |
Enhances collagen production, reduces oxidative stress and inflammation |
The combination of BPC-157, TB-500, and GHK-Cu offers a multi-faceted approach to tissue regeneration, improving healing time, tissue quality, and overall recovery. Each peptide targets different aspects of the healing process, and when used together, they enhance each other’s effectiveness.
Together, these three peptides stimulate angiogenesis (the formation of new blood vessels), collagen synthesis, and cell migration. These processes are vital for effective tissue repair. Their synergistic effects lead to faster healing and a more complete recovery compared to using each peptide alone. BPC-157 promotes vascular support and reduces inflammation, ensuring a better oxygen and nutrient supply to the damaged tissues. TB-500, with its unique ability to enhance cell migration, ensures that repair cells are effectively recruited to the injury site. Meanwhile, GHK-Cu strengthens the newly formed tissue by promoting collagen production, improving its structure and elasticity. This combination speeds up recovery and enhances tissue regeneration in a way that no single peptide could achieve on its own.
Scar formation is a natural part of the healing process, but excessive scarring can impair tissue function. The combination of BPC-157 and TB-500 helps minimize scar tissue formation by reducing fibrosis, which is the thickening and scarring of connective tissue. BPC-157 promotes healing by increasing collagen production and regulating the repair process. TB-500 enhances the mobility of repair cells, ensuring that new tissue forms correctly. On top of that, GHK-Cu works to organize the newly formed tissue, improving its flexibility and functionality. By guiding the regeneration process and reducing fibrosis, these peptides work together to produce smoother, more functional tissue with less visible scarring.
BPC-157, TB-500, and GHK-Cu target different stages of tissue regeneration. BPC-157 enhances the initial stages of healing by promoting blood vessel formation and reducing inflammation, creating an ideal environment for tissue repair. TB-500 accelerates the migration of cells to the damaged area, ensuring that repair processes occur more quickly and efficiently. GHK-Cu, which supports collagen synthesis, ensures that the new tissue has strength and structure, contributing to the overall stability of the healed tissue. By working in harmony, these peptides provide a comprehensive solution to tissue regeneration, improving not just the speed of healing but the quality of the repaired tissue. The result is not only a healed injury but also a stronger and more functional tissue, ensuring that the body recovers in the best possible way.
Together, BPC-157, TB-500, and GHK-Cu offer an incredibly effective approach to healing, addressing multiple layers of tissue regeneration. This powerful synergy accelerates recovery, reduces scarring, and enhances the structural integrity of the healed tissue, making it a valuable tool for a variety of medical and therapeutic applications.
|
Peptide Combination |
Combined Effect |
Specific Applications |
|
BPC-157 + TB-500 |
Enhanced tissue regeneration, faster healing |
Tendon and ligament injuries, post-surgical recovery |
|
TB-500 + GHK-Cu |
Boosts collagen synthesis, reduces scar formation |
Muscle recovery, skin healing, scar tissue reduction |
|
BPC-157 + TB-500 + GHK-Cu |
Accelerated healing, reduced inflammation, improved tissue quality |
Comprehensive healing across multiple tissue types (musculoskeletal, skin, gastrointestinal) |
The synergistic effects of BPC-157, TB-500, and GHK-Cu have been demonstrated in numerous studies, especially in the context of musculoskeletal injuries, skin healing, and gastrointestinal repairs. Their combined use has shown promise in accelerating recovery from injuries, reducing chronic inflammation, and promoting overall tissue health.
In animal models, BPC-157 and TB-500 have been shown to accelerate the healing of tendons, ligaments, and muscles. GHK-Cu, although less studied in orthopedic injuries, has demonstrated promise in improving bone and cartilage regeneration. Together, these peptides offer a powerful approach for healing musculoskeletal injuries faster and more effectively.
GHK-Cu’s ability to promote collagen synthesis has made it a popular peptide in the field of aesthetics. When combined with BPC-157 and TB-500, it offers a comprehensive solution for skin regeneration, improving wound healing, and reducing scarring. This combination is increasingly used in regenerative dermatology for its ability to enhance skin elasticity and reduce the appearance of fine lines and wrinkles.
BPC-157 has been widely studied for its effects on gastrointestinal health. It has been shown to promote the healing of ulcers, inflammatory bowel disease, and even complex gastrointestinal fistulas. When combined with TB-500 and GHK-Cu, BPC-157’s effects are enhanced, resulting in faster and more complete gastrointestinal tissue repair.
|
Tissue Type |
BPC-157 |
TB-500 |
GHK-Cu |
|
Muscle |
Promotes muscle recovery, reduces inflammation |
Increases cell migration, accelerates recovery |
Supports collagen production, reduces muscle damage |
|
Tendon/Ligament |
Stimulates collagen production, accelerates healing |
Promotes tendon healing, reduces fibrosis |
Helps with tissue integrity and regeneration |
|
Skin |
Promotes skin tissue regeneration, reduces scars |
Enhances skin repair and flexibility |
Boosts collagen synthesis, rejuvenates skin cells |
|
Gastrointestinal |
Speeds up gut healing, reduces inflammation |
N/A |
Promotes epithelial cell repair, reduces oxidative stress |
BPC-157, TB-500, and GHK-Cu are a powerful combination for tissue regeneration. Their synergistic effects promote faster healing, reduce inflammation, and improve tissue quality. These peptides hold great promise in regenerative medicine, offering solutions for musculoskeletal, skin, and gastrointestinal healing. As research progresses, their combined use may revolutionize tissue regeneration and recovery. Products from Peplyte can support your health, offering effective regenerative solutions.
A: BPC-157, TB-500, and GHK-Cu are peptides known for their regenerative properties. They promote tissue healing, reduce inflammation, and stimulate collagen production.
A: These peptides work synergistically by enhancing angiogenesis, cell migration, and collagen synthesis, speeding up tissue repair and improving overall healing.
A: These peptides are beneficial for musculoskeletal injuries, skin rejuvenation, and gastrointestinal healing, improving recovery from various injuries and conditions.
A: These peptides are generally safe when used appropriately, with minimal side effects. Always consult with a healthcare provider for personalized advice.
By Peplyte 30 days ago
ALL ARTICLES AND PRODUCT INFORMATION PROVIDED ON THIS WEBSITE ARE SOLELY FOR INFORMATION DISSEMINATION AND EDUCATIONAL PURPOSES.
The products provided on this website are intended exclusively for in vitro research. In vitro research (Latin: *in glass*, meaning in glassware) is conducted outside the human body. These products are not pharmaceuticals, have not been approved by the U.S. Food and Drug Administration (FDA), and must not be used to prevent, treat, or cure any medical condition, disease, or ailment. It is strictly prohibited by law to introduce these products into the human or animal body in any form.
Overview
SS-31, also known as Elamipretide, is a novel aromatic cationic peptide. SS-31 can freely cross the blood-brain barrier, a property that makes it suitable for the treatment of neurological disorders. The blood-brain barrier serves as a crucial protective barrier for the central nervous system, with most drugs struggling to cross it. However, SS-31 overcomes this limitation, directly reaching the site of neural damage and offering hope for the repair of neural cell damage. It belongs to the class of small-molecule peptides, with a relatively low molecular weight, which confers it with good mobility and bioavailability within the body. The cations carried by SS-31 enable it to interact with negatively charged components of biological membranes, particularly the negatively charged inner membrane phospholipids of mitochondria. This specific binding allows SS-31 to accumulate in mitochondria, thereby exerting its regulatory effects on mitochondrial function.
Figure 1 Mechanism of action of SS-31 against kidney disease.
Mechanism of Action
Regulation of Mitochondrial Function
Mitochondria, as the cell’s energy powerhouse, play a critical role in cellular survival and metabolism. SS-31, with its cationic structure, can widely accumulate in the negatively charged inner membrane phospholipids of mitochondria, thereby enhancing mitochondrial respiration. The mitochondrial respiratory chain is a critical pathway for cellular energy production (ATP). SS-31 optimizes the function of related proteins in the respiratory chain, improving electron transport efficiency, thereby promoting ATP synthesis and providing cells with sufficient energy to maintain normal physiological activities such as cell division, differentiation, and material transport.
SS-31 activates mitochondrial biogenesis in neurons, promoting the generation of new mitochondria. When cells face damage or stress, the generation of new mitochondria helps replenish damaged or dysfunctional mitochondria, maintaining the health of the mitochondrial population within the cell. It also enhances mitochondrial autophagy, the cellular mechanism for clearing damaged mitochondria. If damaged mitochondria are not promptly cleared, they release large amounts of reactive oxygen species (ROS), further damaging cells. SS-31 effectively reduces ROS production by enhancing mitochondrial autophagy, thereby protecting cells from oxidative stress damage.
Inhibiting inflammatory responses
In many cellular damage processes, inflammatory responses often accompany the damage. Cytoplasmic phospholipase A2 (cPLA2), as the primary mediator of neuroinflammation, breaks down membrane phospholipids at the sn-2 position of lysosomes under pathological conditions, producing lysophospholipids and ω3 polyunsaturated fatty acids, leading to lysosomal membrane permeabilization (LMP) and creating an inflammatory environment. SS-31 can downregulate the expression level of phosphorylated cytoplasmic phospholipase A2 (p-cPLA2), inhibit the phosphorylation of cPLA2, thereby reducing the production of inflammatory mediators and alleviating the damage caused by inflammatory responses to cells.
In studies on sepsis-induced myocardial injury, SS-31 was found to inhibit the activation of NF-κB and NLRP3, thereby improving myocardial inflammatory responses. NF-κB is a key regulator of inflammatory signaling pathways, while NLRP3 is a crucial component of the inflammasome. Their activation leads to the release of a large number of inflammatory factors, such as IL-6, IL-1β, and TNF-α. By inhibiting the activation of these two key factors, SS-31 reduces the expression levels of inflammatory factors, alleviates inflammatory damage to myocardial cells, and maintains their normal function.
Promoting autophagy and inhibiting pyroptosis
Autophagy is an important self-protective mechanism within cells that clears damaged organelles, misfolded proteins, and other harmful substances. In studies of spinal cord injury, it was found that SS-31 enhances the levels of autophagy-related proteins such as Beclin-1, VPS34, and LC3, reduces the levels of autophagy substrate proteins such as p62, but does not affect the levels of lysosomal biogenesis-related proteins such as ATP6V1B2 and LAMP1. This indicates that SS-31 can influence the formation of autophagosomes after spinal cord injury, such as p62, without affecting the levels of lysosomal biogenesis-related proteins, such as ATP6V1B2 and LAMP1. This suggests that SS-31 can influence the formation of autophagosomes after spinal cord injury, promote the normal progression of the autophagy pathway, assist cells in clearing damaged components, and restore the stability of the intracellular environment.
Pyroptosis is an inflammatory programmed necrosis that leads to excessive cellular damage in various diseases. SS-31 reduces the levels of pyroptosis-related proteins, such as ASC, GSDMD, Caspase-1, NLRP3, NLRP1, IL-1β, and IL-18, thereby inhibiting the occurrence of pyroptosis. There is a complex interplay between autophagy and pyroptosis; enhancing autophagy can inhibit pyroptosis. SS-31 regulates this balance, effectively reducing cell death caused by pyroptosis and promoting cellular repair and survival.
Applications
Neurological Diseases
Spinal cord injury is a severe disabling condition leading to permanent functional loss and motor impairments. Due to the presence of the blood-brain barrier, conventional drugs struggle to reach the injured site. SS-31, with its ability to cross the blood-brain barrier, shows promising potential in the treatment of spinal cord injury. When administered via intraperitoneal injection to mice with spinal cord injury, behavioral assessments using the BMS mouse scale, gait analysis, and inclined plane test revealed that it significantly promotes functional recovery post-injury. Histologically, using HE, Masson, MAP2, and SYN staining, it was determined that SS-31 reduces the area of spinal cord glial scarring, increases the number of dendrites and synapses, and promotes the structural and functional repair of spinal cord neurons.
In studies of some neurodegenerative diseases, such as Parkinson’s disease and Alzheimer’s disease, SS-31 has also shown potential therapeutic value. These diseases are often accompanied by oxidative stress-induced neuronal damage, inflammatory responses, and mitochondrial dysfunction. SS-31, through multiple mechanisms such as regulating mitochondrial function, inhibiting inflammatory responses, and promoting cellular autophagy, holds promise for delaying neuronal degeneration and improving patient symptoms.
Cardiovascular Diseases
Cardiac dysfunction is a common and life-threatening complication of sepsis. SS-31 exhibits protective effects against myocardial injury in sepsis. In in vivo experiments, mice in the SS-31 intervention group showed significantly improved myocardial tissue disorganization and inflammatory infiltration compared to the sepsis group, and a significant reduction in apoptotic cells. SS-31 can inhibit the upregulation of inflammatory factors in myocardial tissue, increase ATP content, improve redox status, maintain mitochondrial membrane potential, and inhibit the activation of NF-κBp65 and NLRP3, thereby alleviating LPS-induced myocardial injury. This suggests that SS-31 may become a potential drug for treating sepsis-induced cardiomyopathy.
In other cardiovascular diseases, such as myocardial ischemia-reperfusion injury, SS-31 may also play an important role. The myocardial ischemia-reperfusion process leads to the production of a large amount of ROS, triggering inflammatory responses and cell apoptosis.
Conclusion
SS-31 can penetrate the blood-brain barrier, target mitochondria to repair cellular damage, and has potential applications in neurological diseases, cardiovascular diseases, skeletal muscle repair, and diabetic vascular endothelial injury. By targeting mitochondria as the core target, it offers a new therapeutic theory.
Sources
[1] Zhu Y, Luo M, Bai X, et al. SS-31, a Mitochondria-Targeting Peptide, Ameliorates Kidney Disease[J]. Oxidative Medicine and Cellular Longevity, 2022,2022:1295509.DOI:10.1155/2022/1295509.
Product available for research use only:
By Peplyte 27 days ago
ALL ARTICLES AND PRODUCT INFORMATION PROVIDED ON THIS WEBSITE ARE SOLELY FOR INFORMATION DISSEMINATION AND EDUCATIONAL PURPOSES.
The products provided on this website are intended exclusively for in vitro research. In vitro research (Latin: *in glass*, meaning in glassware) is conducted outside the human body. These products are not pharmaceuticals, have not been approved by the U.S. Food and Drug Administration (FDA), and must not be used to prevent, treat, or cure any medical condition, disease, or ailment. It is strictly prohibited by law to introduce these products into the human or animal body in any form.
Overview
Melanotan-1 (MT-1) is an ultra-high-efficiency synthetic melanocyte-stimulating peptide, a synthetic formulation of the naturally occurring hormone melanocortin, which has garnered significant attention in the beauty industry. Melanocortin analogues play a crucial role in skin physiological processes, interacting with specific receptors to regulate melanin production. Melanotan – 1 mimics the natural mechanism of melanocortin, influencing the skin’s pigmentation process, which forms the basis for its application in the beauty industry.
Figure 2 The chemical structure of Melanotan – 1.
Historically, research on Melanotan-1 began with an in-depth exploration of skin pigmentation regulation mechanisms. As people’s pursuit of beauty continues to rise, particularly the demand for skin tanning effects, researchers have increasingly focused on substances that can regulate melanin production.
Mechanism of Action
(1) Binding to Melanocortin Receptors
The key to Melanotan-1’s efficacy lies in its ability to bind to melanocortin receptors (MC1R). MC1R is a G protein-coupled receptor primarily expressed on the surface of melanocytes. When Melanotan-1 binds to MC1R, it triggers a series of intracellular signal transduction events. This binding activates the G protein coupled to MC1R, which in turn activates adenylate cyclase, leading to an increase in the intracellular second messenger cyclic adenosine monophosphate (cAMP) levels. The rise in cAMP further activates protein kinase A (PKA), which regulates the expression of melanin synthesis-related genes by phosphorylating the downstream transcription factor, the microphthalmia-associated transcription factor (MITF).
Figure 2 Association between maximum change in melanin density and baseline melanin density at the inner upper arm in ITT individuals.
(2) Regulation of gene expression related to melanin synthesis
MITF is a key transcription factor in the melanin synthesis process, capable of upregulating the expression of multiple genes encoding enzymes involved in melanin synthesis, with tyrosinase being the most important. Tyrosinase is the rate-limiting enzyme in melanin synthesis, catalyzing the gradual conversion of tyrosine into dopaquinone, which is then synthesized into melanin. Melanotan-1 promotes MITF activity, increases the expression of tyrosinase and other melanin synthesis-related enzymes, thereby accelerating the melanin synthesis process. Melanotan-1 may also influence the expression of other genes related to melanin synthesis, such as dopa-colorin interconverting enzyme (DCT), among others. These enzymes act synergistically to promote melanin synthesis and accumulation, ultimately leading to darker skin color.
(3) Synergistic effects of intracellular signaling pathways
In addition to the classic cAMP-PKA-MITF signaling pathway mentioned above, Melanotan-1 may also regulate melanin synthesis through other intracellular signaling pathways. It may influence the mitogen-activated protein kinase (MAPK) signaling pathway. In melanocytes, the MAPK signaling pathway participates in regulating various biological processes such as cell proliferation, differentiation, and survival. Melanotan-1 may activate the MAPK signaling pathway to further promote melanocyte proliferation and melanin synthesis. The PI3K-Akt signaling pathway may also be associated with the effects of Melanotan-1. This pathway plays a crucial role in cell growth, survival, and metabolic regulation, potentially providing the necessary metabolic foundation for melanin synthesis by regulating intracellular metabolic processes.
Role in the Beauty Industry
(1) Promoting Skin Tanning
Manifestation of Tanning Effects
The most notable cosmetic effect of Melanotan-1 is its ability to promote skin tanning. Studies have shown that after administering Melanotan-1 via subcutaneous injection or other appropriate routes of administration, a significant darkening of skin color can be observed in subjects. In a study involving healthy male volunteers, subcutaneous injection of Melanotan-1 at a dose of 0.08–0.21 mg/kg was administered continuously for 5 days over 2 weeks (10 doses). The results showed significant tanning in areas such as the forehead, arms, and neck of the subjects. This tanning effect is not caused by UV-induced damage but rather by increased endogenous melanin synthesis, resulting in a more even and natural skin tone.
Duration of tanning effect
The skin tanning effect induced by Melanotan-1 has a certain degree of persistence. Studies found that the tanning effect reached its peak approximately one week after administration, and even three weeks after completing the ten-dose regimen, the skin color remained noticeably darker than before treatment. This indicates that Melanotan-1 not only effectively promotes melanin synthesis but also that the melanin produced through this synthesis process can be maintained in the skin for a certain period, thereby sustaining the tanning appearance effect.
(2) Potential skin protective effects
UV protection mechanism
Melanin serves as an important natural barrier for the skin against UV radiation. By increasing melanin synthesis, Melanotan-1 theoretically enhances the skin’s ability to absorb and scatter UV rays, thereby reducing UV-induced damage to skin cells. Melanin absorbs UV energy and converts it into thermal energy for release, thereby lowering the risk of UV-induced damage to biological macromolecules such as DNA and proteins. Additionally, melanin can regulate the skin’s immune system to reduce UV-induced inflammatory responses, further protecting the skin from damage.
Related Research Evidence
Although clinical studies on the direct skin-protective effects of Melanotan-1 are currently limited, its potential for UV protection can be reasonably inferred based on the physiological functions of melanin and Melanotan-1’s ability to promote melanin synthesis. Some in vitro studies have shown that melanocytes treated with Melanotan-1 exhibit relatively lower levels of reactive oxygen species (ROS) and reduced apoptosis rates after UV exposure, suggesting that Melanotan-1 may enhance skin tolerance to UV radiation by boosting melanin synthesis.
(3) Other potential effects on skin appearance
Improved skin texture
Some suggest that Melanotan-1 may have a positive impact on skin texture. Increased melanin synthesis may enhance cellular metabolism, promoting the synthesis and renewal of collagen and elastic fibers. In some small-scale observational studies, some participants reported that their skin became firmer, more elastic, and showed improvements in fine lines and wrinkles after using Melanotan-1. This is related to the regulation of skin extracellular matrix metabolism by intracellular signaling pathways activated during melanin synthesis.
Reduction of skin pigmentation
Some studies have also observed that Melanotan-1 may have a certain改善 effect on skin pigmentation. The formation of skin pigmentation is typically associated with disorders in melanin metabolism. By regulating melanin synthesis and distribution, Melanotan-1 may help distribute melanin more evenly in the skin, thereby reducing the visibility of pigmentation.
Applications in the field of aesthetics
Following subcutaneous injection, Melanotan-1 is completely absorbed by the body, exhibiting the same bioavailability as intravenous administration. In a pharmacokinetic study comparing different routes of administration, subcutaneous injection of Melanotan-1 at doses of 0.08–0.21 mg/kg resulted in detectable drug concentrations in plasma, with a plasma half-life of 0.07–0.79 hours during the absorption phase and 0.8–1.7 hours during the β phase. The advantages of subcutaneous injection include relatively simple administration and stable drug absorption; however, it also has certain limitations, such as potential local pain, redness, and other injection site reactions.
4. Comparison with Other Aesthetic Methods
Comparison with Traditional Sunbathing Methods
Traditional sunbathing is a common method for achieving skin tanning effects, but this method has numerous drawbacks. Prolonged exposure to ultraviolet (UV) radiation increases the risk of skin cancer, photoaging, and other conditions, while also potentially causing sunburn, dryness, and wrinkles. Melanotan-1-induced skin tanning is achieved through increased endogenous melanin synthesis, theoretically avoiding the damage caused by direct UV exposure. However, since the safety of Melanotan-1 has not yet been fully established, it cannot currently completely replace traditional sunbathing as a safe and reliable tanning method.
Comparison with Artificial Tanning Products
There are some artificial tanning products available on the market, such as self-tanning lotions, which typically react with amino acids on the skin’s surface to create a tanned-like color. Compared to Melanotan-1, artificial tanning products act on the skin’s surface, resulting in relatively short-lived effects and may cause issues such as uneven or unnatural coloration. Melanotan-1, on the other hand, alters skin color from within by regulating melanin synthesis, potentially yielding more lasting and natural results.
Conclusion
As a synthetic melanocyte-stimulating hormone peptide, Melanotan-1 primarily functions by binding to melanocyte-stimulating hormone receptors, activating intracellular signaling pathways, and regulating the expression of genes related to melanin synthesis, thereby promoting melanin synthesis. In terms of cosmetic effects, it effectively promotes skin tanning with a certain degree of persistence, and may also have potential skin-protective effects and other positive impacts on skin appearance.
Sources
[1] Habbema L, Halk A B, Neumann M, et al. Risks of unregulated use of alpha-melanocyte-stimulating hormone analogues: a review[J]. International Journal of Dermatology, 2017,56(10):975-980.DOI:10.1111/ijd.13585.
[2] Fitzgerald L M, Fryer J L, Dwyer T, et al. Effect of MELANOTAN, [Nle(4), D-Phe(7)]-alpha-MSH, on melanin synthesis in humans with MC1R variant alleles[J]. Peptides, 2006,27(2):388-394.DOI:10.1016/j.peptides.2004.12.038.
[3] Ugwu S, Blanchard J, Dorr R, et al. Skin pigmentation and pharmacokinetics of melanotan-I in humans[J]. Biopharmaceutics & Drug Disposition, 1997,18:259-269.DOI:10.1002/(SICI)1099-081X(199704)18:33.0.CO;2-X.
Product available for research use only:
By Peplyte 1 month ago
ALL ARTICLES AND PRODUCT INFORMATION PROVIDED ON THIS WEBSITE ARE SOLELY FOR INFORMATION DISSEMINATION AND EDUCATIONAL PURPOSES.
The products provided on this website are intended exclusively for in vitro research. In vitro research (Latin: *in glass*, meaning in glassware) is conducted outside the human body. These products are not pharmaceuticals, have not been approved by the U.S. Food and Drug Administration (FDA), and must not be used to prevent, treat, or cure any medical condition, disease, or ailment. It is strictly prohibited by law to introduce these products into the human or animal body in any form.
1. Introduction
Obesity has become a growing public health concern worldwide, significantly increasing the risk of various complications such as cardiovascular disease and diabetes. Finding effective obesity treatment drugs is of utmost importance. Survodutide, as a dual agonist acting on the glucagon receptor (GCGR) and the glucagon-like peptide-1 receptor (GLP-1R), shows great potential in the field of obesity treatment.
Figure 1 Effects of glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon on various vital organs and tissues.
2. Overview of Survodutide
2.1 Development Background
The global incidence of obesity and type 2 diabetes mellitus (T2DM) continues to rise, and traditional antidiabetic drugs often lead to weight gain, prompting an urgent need for novel therapies that can simultaneously treat T2DM and obesity. GLP-1 receptor agonists (GLP-1 RAs) and dual GLP-1/GIP receptor agonists have demonstrated efficacy in weight loss and metabolic improvement, Survodutide (BI 456906) has emerged as a promising candidate, a long-acting dual agonist currently under investigation.
2.2 Target Mechanism
Survodutide’s unique feature lies in its ability to simultaneously activate GCGR and GLP-1R. GCGR primarily regulates blood glucose levels, promoting glycogenolysis and gluconeogenesis in the liver upon activation, thereby elevating blood glucose levels. In the mechanism of action of Survodutide, it does not simply raise blood glucose levels but instead regulates energy metabolism through synergistic action with GLP-1R. GLP-1R is widely distributed in multiple tissues and organs, including the pancreas, gastrointestinal tract, heart, and brain. Activating GLP-1R promotes insulin secretion, inhibits glucagon secretion, delays gastric emptying, increases satiety, thereby reducing food intake and lowering body weight. Survodutide exerts a more comprehensive metabolic regulatory effect through dual receptor agonism, aiding in the treatment of obesity.
3. The Role of Survodutide in Obesity Treatment
3.1 Weight Regulation Effect
Multiple clinical studies have demonstrated that Survodutide has a significant weight-reducing effect in obese patients. In a Phase 2 clinical trial targeting obese individuals without diabetes, 387 participants aged 18 to 75 years with a body mass index (BMI) ≥27 kg/m² were randomly assigned to five groups, receiving weekly subcutaneous injections of Survodutide (0.6, 2.4, 3.6, or 4.8 mg) or placebo for 46 weeks. At the end of 46 weeks, all Survodutide dose groups showed weight loss, with the 4.8 mg group achieving an average weight reduction of up to 18.7%. From the subgroup analysis by gender and BMI, women showed a more pronounced weight loss after receiving 4.8 mg of Survodutide, with an average weight loss percentage of -17.0%, while men had -11.9%. Among different BMI subgroups, participants with BMI < 30 kg/m² who received Survodutide 4.8 mg treatment experienced the highest weight loss percentage, reaching -19.1%. This indicates that Survodutide has a weight-reducing effect on obese patients of different genders and BMI levels, with more pronounced effects in certain subgroups.
Figure 2 Primary End Point after 48 Weeks of Planned Treatment.
3.2 Effects on Body Fat Distribution
In addition to total weight loss, Survodutide also had beneficial effects on body fat distribution. Compared with the placebo group, all Survodutide dose groups showed a reduction in waist circumference, with the 4.8 mg group achieving the greatest average reduction of 16.6 cm. A reduction in waist circumference indicates a decrease in abdominal fat, which is closely associated with the risk of cardiovascular disease. This suggests that Survodutide not only reduces body weight but also improves body fat distribution by reducing abdominal fat, thereby lowering the risk of obesity-related cardiovascular diseases.
3.3 Improvement in metabolic parameters
Survodutide not only regulates body weight but also has positive effects on multiple metabolic parameters. In terms of lipid metabolism, during the treatment period, triglycerides (TG) decreased significantly in all Survodutide groups, and very low-density lipoprotein (VLDL) decreased slightly in all Survodutide dose groups. LDL decreased in the 2.4 and 3.6 mg dose groups, while total cholesterol (TC) and non-HDL cholesterol (non-HDL-C) decreased in the 0.6, 2.4, and 3.6 mg groups. HDL remained relatively stable throughout treatment. Regarding blood pressure, in actual treatment, Survodutide can reduce systolic blood pressure (SBP) by up to 10.2 mmHg and diastolic blood pressure (DBP) by 4.8 mmHg, with similar blood pressure-lowering effects observed regardless of whether hypertension was present prior to screening. These improvements in metabolic parameters help reduce the risk of cardiovascular disease in obese patients, further highlighting Survodutide’s comprehensive advantages in the treatment of obesity.
3.4 Mechanism of Action
Survodutide exerts its weight-loss effects by activating GCGR and GLP-1R. Activation of GLP-1R promotes insulin secretion, enhances insulin sensitivity, suppresses appetite, and reduces food intake. It also delays gastric emptying, prolonging the time food remains in the stomach and further increasing satiety. Activation of GCGR participates in hepatic metabolic regulation by promoting fat oxidation and inhibiting fat synthesis, thereby reducing fat accumulation in the body. Survodutide may also influence energy metabolism and body weight through indirect mechanisms such as regulating the gut microbiota.
4. Application of Survodutide in the Treatment of Obesity
4.1 Clinical Research Evidence
In a study of patients with type 2 diabetes and obesity, Survodutide also demonstrated good hypoglycemic and weight-loss effects. After 16 weeks of treatment, patients’ hemoglobin A1c (HbA1c) levels significantly decreased, with a maximum reduction of 1.7%, and body weight also decreased significantly, with a maximum reduction of 14.9%. In a study of patients with metabolic dysfunction-associated steatohepatitis (MASH) and obesity, Survodutide not only improved liver histological markers but also led to weight loss in patients. These studies further confirm the efficacy of Survodutide in various populations with obesity-related conditions.
4.2 Comparative Advantages Over Other Drugs
Compared to traditional weight-loss drugs, Survodutide offers multiple advantages. Traditional weight-loss drugs often target a single mechanism, resulting in limited efficacy and a higher risk of adverse effects. Survodutide, however, acts through dual receptor agonism, effectively reducing body weight while simultaneously improving metabolic parameters such as blood glucose, lipid levels, and blood pressure, thereby providing comprehensive prevention and treatment for obesity-related complications.
Compared to other novel weight-loss drugs such as semaglutide (a GLP-1 receptor agonist), in animal experiments, both Survodutide and semaglutide induced weight loss. However, Survodutide exhibited more unique effects on food preferences and lipid abnormalities. Semaglutid reduces food intake in the early stages of treatment but returns to baseline levels later, while Survodutide continuously reduces intake of high-fat diets and high-fructose water over a 5-week treatment period. Regarding lipid profiles, Semaglutid primarily reduces total cholesterol by lowering HDL-cholesterol, while Survodutide demonstrates cholesterol reduction across all lipoprotein components, including LDL-cholesterol. This suggests that Survodutide may offer superior effects in regulating food intake and lipid profiles.
5. Conclusion
Survodutide, as a novel dual agonist of GCGR/GLP-1R, demonstrates significant efficacy in the treatment of obesity. It not only effectively reduces body weight and improves body fat distribution but also comprehensively regulates multiple metabolic parameters such as blood glucose, blood lipids, and blood pressure, offering multifaceted benefits for patients with obesity.
Sources
[1] Yousif A, Hassan E, Mudarres M F, et al. Survodutide, a new horizon in the treatment of obesity and Type 2 diabetes mellitus: A narrative review[J]. Yemen Journal of Medicine, 2024,3:97-101.DOI:10.18231/j.yjom.2024.005.
[2] Le Roux C W, Steen O, Lucas K J, et al. 6926 Subgroup Analysis by Gender and Body Mass Index (BMI) in People Living With Overweight/Obesity in the Survodutide, a Glucagon/GLP-1 Receptor Dual Agonist, Phase II Trial[J]. Journal of the Endocrine Society, 2024,8(Supplement_1):bvae133-bvae163.DOI:10.1210/jendso/bvae163.033.
[3] Sanyal A J, Bedossa P, Fraessdorf M, et al. A Phase 2 Randomized Trial of Survodutide in MASH and Fibrosis.[J]. The New England Journal of Medicine, 2024.
[4] Briand F, Augustin R, Bleymehl K, et al. 7279 Survodutide and Semaglutid Both Induce Weight Loss but Show Different Effects on Food Preference and Dyslipidemia in the Free Choice Diet-induced Obese Hamster Model[J]. Journal of the Endocrine Society, 2024,8(Supplement_1):bvae134-bvae163.DOI:10.1210/jendso/bvae163.034.
[5] Her M B U, Rosenstock J, Hoefler J, et al. Dose–response effects on HbA1c and bodyweight reduction of survodutide, a dual glucagon/GLP-1 receptor agonist, compared with placebo and open-label semaglutide in people with type 2 diabetes: a randomised clinical trial[J]. Diabetologia, 2023,67:470-482.
Product available for research use only:
Did you know peptides like Pinealon can boost brain health and protect against aging? Pinealon is a bioregulator peptide that may improve memory and cognitive function.In this article, we’ll explore how Pinealon works, its benefits for the brain, and how it supports long-term cognitive health.
You’ll learn about its effects on neuroprotection, memory, and cellular aging.Learn more about our products at Peplyte and how they support cognitive health.
Pinealon is a synthetic tripeptide made up of glutamic acid, aspartic acid, and arginine, abbreviated as EDR. It belongs to the family of bioregulator peptides, which are short chains of amino acids derived from various organs. These peptides are believed to regulate specific cellular processes in the tissues from which they are derived. Pinealon’s small molecular size (around 390 daltons) allows it to penetrate both cell membranes and the nucleus, where it interacts with DNA and influences gene expression. This unique ability enables Pinealon to impact brain function by regulating key processes involved in cellular energy production, gene activity, and stress response.
Pinealon’s primary mechanism involves direct interaction with the DNA of brain cells. Through its small size and charge distribution, Pinealon can cross cellular and nuclear membranes, allowing it to bind to specific regions of DNA. This interaction influences the expression of genes related to neuronal survival, stress response, and aging. Pinealon is particularly effective in regulating the activity of genes involved in cell proliferation, antioxidant defense, and apoptosis, which is the process of programmed cell death. By modulating these pathways, Pinealon helps maintain brain cell health and function, offering neuroprotection and supporting cognitive longevity.
Oxidative stress is a key factor in neurodegenerative diseases and cognitive decline. Pinealon plays a critical role in reducing oxidative stress by enhancing the brain’s natural antioxidant defenses. It achieves this by upregulating antioxidant enzymes like superoxide dismutase (SOD), catalase, and glutathione peroxidase (GPx), which neutralize harmful free radicals and reactive oxygen species (ROS). By protecting neurons from oxidative damage, Pinealon helps preserve brain function and may contribute to the prevention of diseases like Alzheimer’s and Parkinson’s.
|
Antioxidant Enzyme |
Pinealon Effect |
General Role in the Brain |
|
Superoxide Dismutase (SOD) |
Increases activity |
Neutralizes superoxide radicals |
|
Catalase |
Boosts activity |
Breaks down hydrogen peroxide |
|
Glutathione Peroxidase (GPx) |
Enhances activity |
Reduces oxidative damage to lipids and proteins |
Mitochondria are the energy powerhouses of cells, and their dysfunction is a hallmark of aging and neurodegeneration. Pinealon has been shown to support mitochondrial function, which is crucial for maintaining cellular energy levels and reducing stress. In animal studies, Pinealon administration resulted in more stable mitochondrial membranes and improved ATP production in neurons, even under conditions of oxidative stress. This mitochondrial support is vital for sustaining cognitive performance, particularly as the brain ages.
Pinealon has demonstrated cognitive-enhancing effects, particularly in the areas of memory and focus. Research in both animal models and human studies suggests that Pinealon can improve memory retention and learning abilities. For example, studies on rats have shown that Pinealon enhances performance in maze tasks and object recognition tests, which are commonly used to measure cognitive function. In addition to memory improvement, Pinealon also helps with focus, which is essential for maintaining attention during mentally demanding tasks.
As we age, cognitive decline becomes inevitable for many individuals. Pinealon shows promise in combating age-related cognitive decline by promoting neuroprotection and enhancing brain cell function. Studies on aging rodents have demonstrated that Pinealon helps preserve cognitive abilities, improve synaptic plasticity, and reduce signs of age-related brain degeneration. These findings suggest that Pinealon may be an effective tool in slowing down the cognitive decline associated with aging and potentially delaying the onset of age-related neurodegenerative diseases.
|
Cognitive Function Area |
Effect of Pinealon |
Evidence/Outcome |
|
Memory Improvement |
Enhances memory retention and learning abilities |
Improved performance in maze and recognition tasks in animal studies |
|
Focus and Attention |
Increases focus and concentration |
Enhances performance in attention-demanding tasks |
|
Prevention of Cognitive Decline |
Reduces age-related cognitive decline and supports neuroplasticity |
Animal studies show preserved cognitive function in aging models |
Pinealon’s ability to regulate gene expression at the epigenetic level is one of its most remarkable features. By interacting with DNA and histone proteins, Pinealon can influence the activity of specific genes involved in brain function. For example, research has shown that Pinealon can upregulate genes responsible for neuronal differentiation and downregulate genes associated with stress-induced apoptosis. This ability to modulate gene activity helps Pinealon promote healthier brain cells and supports cognitive longevity.
In addition to its role in gene regulation, Pinealon also impacts cellular aging. By influencing epigenetic markers such as DNA methylation and histone acetylation, Pinealon helps maintain youthful gene expression patterns in the brain. This epigenetic modulation may help prevent the cellular aging process, reduce the accumulation of senescent cells, and promote the regeneration of healthy neurons. Pinealon’s potential to slow cellular aging could be a key factor in its ability to extend cognitive longevity and prevent neurodegenerative diseases.
Traumatic brain injury (TBI) is a leading cause of long-term cognitive impairment, and Pinealon has shown potential in mitigating the damage caused by such injuries. Research in animal models of TBI has demonstrated that Pinealon can protect neurons from oxidative damage and promote tissue repair after injury. By supporting mitochondrial function and reducing inflammation, Pinealon helps facilitate recovery and preserve cognitive function in the aftermath of brain injury.
Pinealon’s neuroprotective effects extend to ischemic conditions such as stroke and hypoxia (low oxygen levels). Studies have shown that Pinealon helps protect brain cells from damage caused by reduced oxygen supply, a common feature of stroke and other ischemic events. By reducing oxidative stress and modulating apoptosis pathways, Pinealon helps neurons survive and recover under hypoxic conditions, supporting brain health even in challenging circumstances.
While Pinealon is a powerful neuroprotective peptide, it is not the only peptide with similar benefits. Cortexin, another peptide derived from brain tissue, also offers neuroprotection and cognitive enhancement. However, Pinealon is smaller and more stable, which allows for better tissue penetration and more efficient delivery to the brain. Similarly, Epitalon, a peptide from the pineal gland, is known for its anti-aging effects, but Pinealon’s targeted action on gene expression and neuroprotection sets it apart as a more specialized neuroprotective agent.
Pinealon’s unique molecular structure and ability to modulate gene expression at the epigenetic level provide distinct advantages for brain health. Unlike conventional neuroprotective compounds, Pinealon works by fine-tuning multiple cellular pathways, offering broader benefits for neuroprotection, cognitive longevity, and cellular regeneration. Its targeted action on the brain’s molecular machinery makes it a valuable tool for preventing age-related cognitive decline and promoting long-term brain health.
|
Peptide |
Source |
Mechanism of Action |
Key Benefits |
|
Pinealon |
Brain-derived |
Modulates gene expression, antioxidant defense |
Neuroprotection, cognitive longevity, age-related decline prevention |
|
Cortexin |
Brain-derived |
Enhances neuronal regeneration and repair |
Cognitive enhancement, neuroprotection, stress response |
|
Epitalon |
Pineal gland-derived |
Regulates circadian rhythm, antioxidant effects |
Anti-aging, longevity, supports telomere health |
Pinealon is typically administered via subcutaneous injection, with a recommended dose of 1 mg per day. It is usually taken five days a week, with rest days in between to maximize its effects. For optimal results, Pinealon should be injected in the morning or early afternoon to align with its cognitive-enhancing effects. Users should reconstitute the peptide with bacteriostatic water before injecting and store it in the refrigerator to maintain its stability.
Pinealon has been shown to have a low toxicity profile, with few reported side effects. However, as with any peptide therapy, users should consult with a healthcare professional before beginning treatment. Some mild side effects, such as injection site reactions, headache, or fatigue, may occur, but these are typically short-lived. Pinealon is considered safe for long-term use, but further studies are needed to establish its long-term safety profile fully.
Pinealon peptide is a powerful bioregulator that offers neuroprotection, cognitive longevity, and epigenetic regulation. It helps maintain brain function, reduce oxidative stress, and support mitochondrial health. Its unique mechanism sets it apart from other peptides, making it a valuable tool for promoting long-term brain health.
As research progresses, Pinealon may become crucial for preserving cognitive function and combating neurodegenerative diseases. With continued development, Pinealon can support healthy aging and brain recovery.
At Peplyte, we provide products designed to enhance cognitive health and support neuroprotective therapies.
A: Pinealon peptide is a bioregulator that enhances neuroprotection, cognitive longevity, and epigenetic regulation. It works by modulating gene expression, reducing oxidative stress, and supporting mitochondrial health.
A: Pinealon peptide helps protect against cognitive decline by reducing oxidative stress, supporting mitochondrial function, and promoting healthy gene expression within brain cells.
A: Yes, Pinealon peptide has shown potential in preventing age-related cognitive decline by supporting brain function and promoting neuroplasticity, helping maintain cognitive health.
A: Pinealon peptide’s unique ability to modulate gene expression and support mitochondrial health sets it apart, offering long-term neuroprotection and cognitive benefits not seen in other peptides.
By Peplyte 1 month ago
ALL ARTICLES AND PRODUCT INFORMATION PROVIDED ON THIS WEBSITE ARE SOLELY FOR INFORMATION DISSEMINATION AND EDUCATIONAL PURPOSES.
The products provided on this website are intended exclusively for in vitro research. In vitro research (Latin: *in glass*, meaning in glassware) is conducted outside the human body. These products are not pharmaceuticals, have not been approved by the U.S. Food and Drug Administration (FDA), and must not be used to prevent, treat, or cure any medical condition, disease, or ailment. It is strictly prohibited by law to introduce these products into the human or animal body in any form.
1. Overview
Tadalafil, as a long-acting phosphodiesterase-5 (PDE-5) inhibitor, offers new avenues for the treatment of various conditions and the improvement of physical performance.
Figure 1 Mean changes from baseline, with 95% confidence intervals (CIs), in the 6-minute walking distance at week 16 in the tadalafil and placebo groups.
2. Effects on Blood Circulation
Vasodilation Mechanism: In the human body, the nitric oxide (NO) – cyclic guanosine monophosphate (cGMP) – PDE5 signaling pathway plays a key role in regulating vascular smooth muscle. When endothelial cells release NO upon stimulation, NO activates guanylate cyclase, promoting the conversion of guanosine triphosphate (GTP) to cGMP. As an intracellular second messenger, cGMP activates protein kinase G (PKG), leading to vasodilation of vascular smooth muscle, increased vascular diameter, and enhanced blood flow. The mechanism of action of Tadalafil is to inhibit PDE5 activity, reducing cGMP degradation, thereby maintaining higher levels of cGMP within cells and sustaining its vasodilatory effects to improve blood circulation.
Effects on Different Vascular Beds
Pulmonary circulation: In the pulmonary circulation, Tadalafil is widely used to treat pulmonary arterial hypertension (PAH). In PAH patients, increased pulmonary vascular resistance leads to increased right ventricular workload, which in turn affects cardiac function and systemic blood circulation. Tadalafil dilates pulmonary vessels, reduces pulmonary vascular resistance, alleviates right ventricular afterload, improves pulmonary circulation hemodynamics, increases cardiac output, thereby enhancing patients’ exercise tolerance and quality of life. PAH patients receiving 40 mg of Tadalafil once daily experienced significant improvements in exercise capacity and delayed clinical worsening.
Systemic Circulation: In the systemic circulation, Tadalafil also exerts beneficial effects on blood vessels. It dilates peripheral arteries, reduces peripheral vascular resistance, and improves limb blood perfusion. For patients with peripheral vascular diseases, such as intermittent claudication, Tadalafil can increase blood supply to lower limb muscles, alleviate ischemia symptoms during exercise, and improve walking distance and exercise capacity. Tadalafil may also improve coronary artery blood flow reserve and potentially enhance myocardial perfusion in patients with coronary artery disease, although further research is needed to confirm these effects.
Microcirculation: Microcirculation is a critical site for material exchange between human tissues and blood. Tadalafil improves microcirculatory vessel dilation, increases the number of open capillaries, and enhances tissue blood perfusion and oxygen supply. In some studies, it was found that after Tadalafil treatment, microcirculatory blood flow velocity in skin and muscle tissues accelerated, facilitating smoother nutrient delivery and metabolic waste removal, thereby helping to maintain normal physiological functions of tissues.
3. Applications in improving physical performance
Enhancing exercise endurance
Patients with congenital heart disease: For patients with congenital heart disease, particularly those with single ventricle function who have undergone Fontan surgery, post-operative exercise endurance often decreases. Tadalafil, through its vasodilatory effects, reduces pulmonary vascular resistance and systemic vascular resistance, improves cardiac hemodynamics, and increases cardiac output, thereby providing muscles with more oxygen and nutrients during exercise. In 16 patients who underwent Fontan surgery, after receiving Tadalafil treatment (initially 10mg once daily, then 10mg every 12 hours after 2 weeks, for a total of 6 months), the average 6-minute walk distance increased from 418.75m to 439.06m, and the maximum oxygen uptake (VO2 max) increased from 0.84 L/min to 1.07 L/min, indicating a significant improvement in exercise endurance.
Healthy population: Tadalafil may also have a positive impact on exercise endurance in healthy individuals. Although large-scale studies in healthy populations are currently limited, some small-scale studies suggest that Tadalafil can improve blood circulation during exercise, enabling muscles to receive adequate oxygen supply during physical activity, delaying the onset of fatigue, and potentially enhancing athletic performance. In certain endurance sports, athletes reported improved respiratory comfort and enhanced exercise endurance after using Tadalafil; however, further rigorous scientific research is needed to confirm these findings.
Improved muscle function: Normal muscle function depends on adequate blood supply and oxygenation. By improving blood circulation, Tadalafil can provide muscles with more oxygen and nutrients, promoting energy metabolism. It may also positively influence muscle contraction and relaxation functions by regulating intracellular signaling pathways. In animal experiments, animals treated with Tadalafil exhibited enhanced muscle strength and endurance. For patients with muscle diseases or muscle atrophy caused by prolonged bed rest, Tadalafil may improve local blood circulation, promote muscle repair and regeneration, and enhance muscle function.
Improved daily physical performance: For patients with erectile dysfunction (ED), Tadalafil not only improves erectile function but also has a positive impact on overall physical performance and quality of life. ED patients often experience psychological stress due to their condition, which affects their enthusiasm for daily activities and physical performance. Tadalafil improves blood flow to the penile corpus cavernosum, restoring erectile function, while also boosting patients’ confidence, enabling them to be more proactive in daily life. Additionally, for patients with benign prostatic hyperplasia (BPH) and lower urinary tract symptoms (LUTS), Tadalafil can improve urinary function by relaxing the smooth muscles of the prostate and bladder neck, alleviating physical discomfort caused by urinary difficulties, and thereby enhancing patients’ daily physical performance and quality of life.
4. Summary
Tadalafil demonstrates significant effects in improving blood circulation and physical performance. Whether in the treatment of cardiovascular diseases such as pulmonary arterial hypertension and peripheral vascular disease, or in enhancing exercise tolerance, improving muscle function, and increasing daily physical performance in patients with congenital heart disease, it plays an important role.
Sources
[1] Kaku Y, Chiba K, Sato K, et al. Protective effects of tadalafil against cisplatin-induced spermatogenic dysfunction[J]. Biochemical and Biophysical Research Communications, 2022,603:123-129.DOI:10.1016/j.bbrc.2022.02.113.
[2] Kwak D, Yoo B. Daily Dose of 5 mg Tadalafil Safely Improves Erectile Function and Liver Function Enzymes in Smokers[J]. Journal of Men’s Health, 2022,18:150.DOI:10.31083/j.jomh1807150.
[3] Yang Z, Wang L, Tian L, et al. Tadalafil-loaded PLGA microspheres for pulmonary administration: preparation and evaluation[J]. Brazilian Journal of Pharmaceutical Sciences, 2019. https://api.semanticscholar.org/CorpusID:214115397.
[4] Mónica F Z, De Nucci G. Tadalafil for the treatment of benign prostatic hyperplasia[J]. Expert Opinion On Pharmacotherapy, 2019,20(8):929-937.DOI:10.1080/14656566.2019.1589452.
[5] Khajali Z, Peighambari M M, Lotfian S, et al. Tadalafil and exercise capacity after fontan operation[J]. Research in Cardiovascular Medicine, 2018,7:64-68. https://api.semanticscholar.org/CorpusID:81298947.
[6] E N G, Brundage B H, Ghofrani H A, et al. Tadalafil Therapy for Pulmonary Arterial Hypertension[J]. Circulation, 2009,119:2894-2903. https://api.semanticscholar.org/CorpusID:9916876.
[7] Coward R M, Carson C. Tadalafil in the treatment of erectile dysfunction[J]. Therapeutics and Clinical Risk Management, 2008,4:1315-1330. https://api.semanticscholar.org/CorpusID:7054657.
Product available for research use only:
By Peplyte 1 month ago
ALL ARTICLES AND PRODUCT INFORMATION PROVIDED ON THIS WEBSITE ARE SOLELY FOR INFORMATION DISSEMINATION AND EDUCATIONAL PURPOSES.
The products provided on this website are intended exclusively for in vitro research. In vitro research (Latin: *in glass*, meaning in glassware) is conducted outside the human body. These products are not pharmaceuticals, have not been approved by the U.S. Food and Drug Administration (FDA), and must not be used to prevent, treat, or cure any medical condition, disease, or ailment. It is strictly prohibited by law to introduce these products into the human or animal body in any form.
Overview
Cellular aging is an important biological process in living organisms and is closely related to numerous physiological and pathological phenomena. As age increases, cellular aging gradually accumulates, leading to the decline of tissue and organ function and triggering various age-related diseases. Peptides, as a class of important bioactive molecules, have garnered significant attention in the field of cellular aging research in recent years. Research indicates that peptides play a key role in regulating the cellular aging process. Exploring the relationship between peptides and cellular aging is of great significance for elucidating the mechanisms of aging and developing anti-aging interventions.
Figure 1. Mechanisms of skin aging processes. (a) Free radicals and oxidative stress theory. Mitochondria produce ROS through oxidative metabolism. Excessive ROS can damage the mitochondrial and DNA structures, leading to a decrease in collagen levels and an increase in MMP levels in skin tissue. (b) Inflammation theory. Senescent fibroblasts and keratinocytes secrete a large number of senescence-associated secretory phenotypes, including TNF-α, IL-1, IL-6, IFN-γ and MMPs. These proinflammatory cytokines induce skin cell senescence by promoting ROS production and activating the ATM/ p53/p21-signaling pathway. (c) Photoaging theory. Ultraviolet irradiation induces the production of ROS and the secretion of MMPs, which degrades skin extracellular matrix components such as collagen. (d) Nonenzymatic glycosyl chemistry theory. Non-enzymatic glycosylation is a reaction between free reducing sugars and free amino groups of proteins, DNA and lipids to produce AGEs and ROS. The accumulation of AGEs, together with ROS, can lead to changes in the cell homeostasis and protein structure.
Cellular Aging
(1) Concept and Characteristics of Cellular Aging
Cellular aging refers to the irreversible growth arrest state that cells enter after undergoing a certain number of divisions or being exposed to specific stressors. It exhibits a series of typical characteristics, such as changes in cell morphology, including increased cell volume, flattening, and vacuolization of the cytoplasm; cell cycle arrest, with cells no longer proliferating; and increased activity of senescence-associated β-galactosidase (SA-β-gal), which is currently one of the most widely used markers of cellular senescence. Altered secretory phenotype, where cells secrete various cytokines, chemokines, and proteases, forming the senescence-associated secretory phenotype (SASP).
(2) Consequences of Cellular Senescence
Deterioration of tissue and organ function
Cells are the basic building blocks of tissues and organs, and cellular senescence leads to impaired tissue and organ function. In skin tissue, senescent fibroblasts reduce the synthesis of collagen and elastic fibers, causing the skin to lose elasticity, develop wrinkles, and have impaired repair capacity. In the cardiovascular system, senescent endothelial cells can lead to stiffened blood vessel walls and reduced elasticity, increasing the risk of cardiovascular disease. In the immune system, the aging of immune cells weakens the body’s immune defense function, making individuals more susceptible to pathogen invasion and reducing their immune response to vaccines.
Association with age-related diseases
Cell aging is considered an important driving factor in many age-related diseases. In neurodegenerative diseases such as Alzheimer’s disease and Parkinson’s disease, neuronal aging is closely associated with pathological processes such as neuronal death and neuroinflammation. In diabetes, the aging of pancreatic β cells can lead to insufficient insulin secretion, affecting normal blood glucose regulation. Cell senescence also has a complex relationship with tumorigenesis and tumor progression. Early cell senescence can act as a tumor suppression mechanism, preventing the unlimited proliferation of damaged cells. However, in the tumor microenvironment, SASP components secreted by senescent cells may promote tumor cell growth, invasion, and metastasis.
Peptides
(1) Definition and structure of peptides
Peptides are short-chain compounds formed by amino acids linked via peptide bonds. Based on the number of amino acid residues they contain, they can be classified into dipeptides, tripeptides, tetrapeptides, and polypeptides, among others. Polypeptides are longer, continuous, and unbranched peptide chains. Typically, peptide chains containing no more than 50 amino acids are classified as peptides to distinguish them from proteins. All peptide chains, except for cyclic peptides, have an N-terminal (amino-terminal) and a C-terminal (carboxy-terminal) residue.
(2) Classification of Peptides
Classification by Source
Endogenous peptides: synthesized by the organism itself and perform various physiological functions within the body. Neuropeptides, which participate in signal transmission and regulation within the nervous system, including endorphins and enkephalins, which have analgesic and mood-regulating effects; hormone peptides, such as insulin, which are crucial for regulating blood sugar balance.
Exogenous peptides: obtained from food or other external sources. For example, certain food proteins can be hydrolyzed by digestive enzymes to produce bioactive peptides, such as milk peptides, which have multiple physiological functions, including antioxidant and immune-modulating effects. Peptides prepared through chemical synthesis or biotechnology also fall under exogenous peptides and are commonly used in drug development and clinical therapy.
Classification by Function
Antioxidant Peptides: Capable of scavenging free radicals in the body and reducing oxidative stress-induced damage to cells. For example, rice bran antioxidant peptides have been shown to enhance the activity of antioxidant enzymes such as catalase (CAT) and glutathione peroxidase (GSH-Px) in the mitochondria of heart and brain tissues of D-galactose-induced aged mice, reduce the level of mitochondrial DNA deletion mutations in the brain, and protect cells.
Immune-modulating peptides: These regulate the body’s immune function, enhancing or suppressing immune responses. Some peptides derived from marine organisms can activate immune cells, enhance the body’s immune defense capabilities, and aid in resisting pathogen infections and tumor development.
Cell growth-regulating peptides: These influence cellular processes such as proliferation, differentiation, and apoptosis. For example, epidermal growth factor (EGF) promotes the proliferation and differentiation of epidermal cells, accelerating wound healing.
The role of peptides in cellular aging
(1) Regulation of mitochondrial function
Mitochondria play a key role in cellular energy production and signal transduction, and their dysfunction is closely related to cellular aging. Mitochondria-derived peptides (MDPs) such as humanin and MOTS-c play important regulatory roles in the cellular aging process. Following senescence induced by replicative exhaustion, doxorubicin, or hydrogen peroxide treatment in primary human fibroblasts, mitochondrial numbers increase, mitochondrial respiratory levels rise, and humanin and MOTS-c levels also elevate. Administration of humanin and MOTS-c moderately increases mitochondrial respiration in doxorubicin-induced senescent cells and partially regulates SASP components via the JAK pathway, indicating that MDPs play an important role in mitochondrial energy metabolism and SASP production in senescent cells.
Figure 2 Mitochondrial mass and energetics are altered during doxorubicin-induced senescence. (A) Mitochondrial DNA (mtDNA) copy number in non-senescent (quiescent) and senescent cells. (B) Representative images of Tom20 (green; mitochondria) and Hoechst 33258 (blue; nucleus) immunostaining in non-senescent (quiescent) and senescent cells. Scale bar, 20 μm. The area of Tom20 staining per cell was measured using ImageJ. (C) Cellular ATP levels in non-senescent (quiescent) and senescent cells. (D) Cellular oxygen consumption rate (OCR) in non-senescent and senescent cells. Basal respiration, spare respiratory capacity, and ATP production are calculated based on the sequential compound injection according to the manufacturer’s instructions. (E) The extracellular acidification rate (ECAR) in non-senescent (quiescent) and senescent cells.
(2) Effects on aging-related signaling pathways
p53-p21 pathway
The p53 protein is a key regulator of cellular senescence. When cells are exposed to stressors such as DNA damage, p53 is activated, inducing the expression of p21, which causes the cell cycle to arrest at the G1 phase, leading to cellular senescence. Certain peptides can modulate the p53-p21 pathway, thereby influencing the progression of cellular senescence. Some small-molecule peptides can interact with the p53 protein, inhibiting its activity and thereby delaying cellular senescence. Studies have shown that specific peptides can block the interaction between p53 and MDM2 (a protein that negatively regulates p53), stabilizing the p53 protein and maintaining it at an appropriate level to avoid excessive activation leading to cellular senescence.
Rb-E2F pathway
The Rb protein is another important cell cycle regulatory protein that binds to the E2F transcription factor to inhibit the expression of cell cycle-related genes. When the Rb protein is phosphorylated and inactivated, E2F is released, promoting cell entry into the S phase for DNA replication. During cellular senescence, alterations in the Rb-E2F pathway lead to cell cycle arrest. Certain peptides can regulate cellular senescence by modulating the phosphorylation state of Rb protein or influencing E2F activity. Some peptides can inhibit Rb protein phosphorylation, maintaining the stability of the Rb-E2F complex and thereby delaying cellular senescence.
(III) Regulation of SASP
SASP comprises various cytokines, chemokines, and proteases, among others. Its secretion not only affects the microenvironment of senescent cells themselves but also influences surrounding tissues and cells, promoting inflammatory responses and tissue senescence. Some peptides can regulate SASP production and mitigate its harmful effects. Certain plant-derived peptides have also been found to regulate SASP by inhibiting the activation of specific signaling pathways and reducing the expression of SASP-related factors.
Applications of Peptides in Delaying Cellular Aging
(1) Applications in Skincare Products
With increasing public concern about skin aging, peptides have found widespread application in the skincare industry. For example, some skincare products containing peptides claim to have anti-wrinkle and skin-firming effects. Research indicates that certain peptides can promote collagen synthesis and enhance skin elasticity. Peptides can also regulate skin cell metabolism, enhance skin barrier function, reduce damage to skin cells caused by external factors such as UV radiation, and slow down the skin aging process.
Figure 3 Aging in younger to older skin.
(2) Applications in Drug Development
Treatment of Neurodegenerative Diseases
Peptide drug development holds great promise for addressing neuronal aging in neurodegenerative diseases. Peptides that regulate intracellular signaling pathways, promote neuronal survival, and facilitate repair have been developed for the treatment of Alzheimer’s disease and Parkinson’s disease. Certain peptides can inhibit the aggregation of abnormal proteins within neurons, reduce neuroinflammation, and delay neuronal aging and death. A peptide named AC-5216 can inhibit the aggregation of β-amyloid proteins and improve cognitive function in Alzheimer’s disease model mice.
Treatment of Cardiovascular Diseases
In the treatment of cardiovascular diseases, peptide drugs can target pathological processes such as vascular endothelial cell aging and myocardial cell aging. For example, certain vasoactive peptides can regulate vascular tone and endothelial cell function, improve the aging state of vascular endothelial cells, and reduce the risk of cardiovascular diseases. Some peptides can also promote the repair and regeneration of myocardial cells, offering potential applications in the treatment of conditions such as myocardial infarction.
Conclusion
Cell aging, as a complex biological process, influences the health and aging process of the body. Peptides, as an important class of bioactive molecules, play multifaceted roles in regulating cell aging. Through regulating mitochondrial function, intervening in aging-related signaling pathways, and modulating SASP, peptides demonstrate the ability to delay cell aging.
Sources
[1] Kalidas C, Sangaranarayanan M V. Peptides[M]//Kalidas C, Sangaranarayanan M V. Biophysical Chemistry: Techniques and Applications. Cham: Springer Nature Switzerland, 2023:129-141.
[2] He X, Wan F, Su W, et al. Research Progress on Skin Aging and Active Ingredients[J]. Molecules, 2023,28(14},ARTICLE-NUMBER = {5556).DOI:10.3390/molecules28145556.
[3] Altay Benetti A, Tarbox T, Benetti C. Current Insights into the Formulation and Delivery of Therapeutic and Cosmeceutical Agents for Aging Skin[J]. Cosmetics, 2023,10(2},ARTICLE-NUMBER = {54).DOI:10.3390/cosmetics10020054.
[4] Wong P F. Editorial: Cellular Senescence: Causes, Consequences and Therapeutic Opportunities[J]. Frontiers in Cell and Developmental Biology, 2022,10:884910.DOI:10.3389/fcell.2022.884910.
[5] Zonari A, Brace L E, Al-Katib K, et al. Senotherapeutic peptide reduces skin biological age and improves skin health markers[J]. Biorxiv, 2020. https://api.semanticscholar.org/CorpusID:226263850.
[6] Kim S J, Mehta H H, Wan J, et al. Mitochondrial peptides modulate mitochondrial function during cellular senescence[J]. Aging (Albany Ny), 2018,10(6):1239-1256.DOI:10.18632/aging.101463.
[7] Garrido A M, Bennett M. Assessment and consequences of cell senescence in atherosclerosis[J]. Current Opinion in Lipidology, 2016,27(5):431-438.DOI:10.1097/MOL.0000000000000327.
By Peplyte 31 days ago
ALL ARTICLES AND PRODUCT INFORMATION PROVIDED ON THIS WEBSITE ARE SOLELY FOR INFORMATION DISSEMINATION AND EDUCATIONAL PURPOSES.
The products provided on this website are intended exclusively for in vitro research. In vitro research (Latin: *in glass*, meaning in glassware) is conducted outside the human body. These products are not pharmaceuticals, have not been approved by the U.S. Food and Drug Administration (FDA), and must not be used to prevent, treat, or cure any medical condition, disease, or ailment. It is strictly prohibited by law to introduce these products into the human or animal body in any form.
Overview
Cardiogen, a substance of significant interest in the field of cardiovascular health maintenance, has a source and nature that are crucial to understanding its role in cardiovascular health maintenance. It interacts with specific targets within the cardiovascular system, thereby exerting its health-maintaining effects on the cardiovascular system.
Figure 1. Epigenetic mechanisms in cardiovascular disorders. The heart (center) connects to three major epigenetic regulatory mechanisms influencing cardiovascular pathophysiology.
Effects
Effects on the heart
Regulation of heart rate: Cardiogen can precisely regulate the heart’s rhythm, keeping the heart rate within the normal range. Under stress conditions, such as when the body is stimulated by stress hormones like adrenaline, the heart may experience tachycardia. Cardiogen effectively compensates for the stress effects of adrenaline on the heart, helping to lower the heart rate to normal control values while reducing the occurrence of arrhythmias, thereby maintaining normal cardiac pumping function and ensuring adequate blood supply to the entire body.
Promoting myocardial regeneration: Following cardiac diseases such as myocardial infarction, myocardial tissue is damaged. Cardiogen has a significant role in promoting myocardial regeneration by inducing endogenous mesenchymal stem cells (MSCs) to differentiate into cardiomyocytes, thereby repairing damaged myocardial tissue. By stimulating relevant signaling pathways—key pathways involved in embryonic heart induction and angiogenesis—it promotes the regeneration and proliferation of cardiomyocytes, thereby improving cardiac function and enhancing the heart’s contractile and diastolic capabilities.
Effects on blood vessels
Improving vascular endothelial function: Vascular endothelial cells are crucial for maintaining normal physiological functions of blood vessels. Cardiogen promotes the health of vascular endothelial cells and enhances their ability to secrete vasodilatory substances such as nitric oxide. Nitric oxide relaxes vascular smooth muscle, thereby dilating blood vessels, reducing vascular resistance, improving blood circulation, and lowering the risk of cardiovascular diseases.
Inhibiting vascular inflammation: Inflammatory responses play a significant role in the development of vascular diseases such as atherosclerosis. Cardiogen can suppress inflammatory responses within the vascular wall, reducing the infiltration of inflammatory cells and the release of inflammatory factors. By inhibiting inflammatory cascades, it alleviates damage to the vascular wall, helping to maintain normal vascular structure and function and prevent vascular narrowing and blockages.
Applications
Myocardial infarction treatment: For patients with myocardial infarction, early intervention with Cardiogen after the onset of the disease can promote myocardial regeneration and repair, reduce the infarct area, and improve cardiac function. Administration can be via oral or injection routes, with specific administration routes and doses adjusted individually based on the patient’s condition and physical status. Clinical studies have shown that patients with myocardial infarction who receive Cardiogen treatment exhibit significant improvements in cardiac function indicators such as ejection fraction, thereby enhancing their quality of life and survival rates.
Arrhythmia treatment: Cardiogen can regulate heart rate and stabilize arrhythmia for various types of arrhythmia. For patients with mild arrhythmia, treatment with Cardiogen can reduce the frequency and severity of arrhythmia episodes, avoiding or reducing the side effects associated with traditional antiarrhythmic drugs. In clinical practice, doctors will use Cardiogen appropriately based on the patient’s electrocardiogram monitoring results and symptom manifestations.
Related Research
Animal Experiment Studies: Multiple animal experiments have conducted in-depth investigations into Cardiogen’s cardiovascular protective effects. In rat experiments, after establishing a myocardial infarction model and administering Cardiogen intervention, significant myocardial regeneration was observed in the myocardial infarction area, with cardiac function indicators such as left ventricular ejection fraction significantly improved. Additionally, in vascular-related experiments, it was observed that Cardiogen could inhibit vascular endothelial proliferation and reduce the formation of atherosclerotic plaques, indicating its good protective effects on blood vessels. These animal experiments provide important theoretical foundations and experimental evidence for the application of Cardiogen in cardiovascular and cerebrovascular health maintenance.
Clinical Studies: Some small-scale clinical studies have also conducted preliminary assessments of the safety and efficacy of Cardiogen. In studies targeting patients with arrhythmia, it was found that after treatment with Cardiogen, patients’ arrhythmia symptoms improved significantly, and no severe adverse reactions occurred, demonstrating its potential application value in the treatment of arrhythmia. In clinical studies of myocardial infarction patients, it was observed that patients treated with Cardiogen had better cardiac function recovery than the control group, further confirming its therapeutic effect on myocardial infarction.
Conclusion
In summary, Cardiogen plays an important role in cardiovascular health maintenance. Through its multifaceted effects on the heart and blood vessels, it holds significant application potential in both clinical treatment and daily health maintenance.
Sources
[1] Martínez-Iglesias O, Naidoo V, Carrera I, et al. Natural Bioproducts with Epigenetic Properties for Treating Cardiovascular Disorders[J]. Genes, 2025,16(5},
ARTICLE-NUMBER = {566). DOI:10.3390/genes16050566.
[2] Lin X, Peng P, Cheng L, et al. A natural compound induced cardiogenic differentiation of endogenous MSCs for repair of infarcted heart[J]. Differentiation, 2012,83(1):1-9.DOI:10.1016/j.diff.2011.09.001.
[3] Cheng L, Chen H, Yao X, et al. A plant-derived remedy for repair of infarcted heart[J]. Plos One, 2009,4(2):e4461.DOI:10.1371/journal.pone.0004461.
Product available for research use only:
Have you heard about Vilon peptide and its potential for boosting immunity and cellular health? This powerful peptide is derived from thymic tissue and plays a vital role in immune support and tissue repair.
In this article, we’ll explore how Vilon works, its benefits for regeneration, and its role in immune health.
Learn more about our products at Peplyte and how they can enhance your health.
Vilon peptide, composed of two amino acids—lysine and glutamic acid—was first discovered in the 1980s as part of a research initiative into thymus-derived peptides. These peptides were found to support cellular processes essential for maintaining immune function and tissue repair. Vilon, also known as Lys-Glu, is one of the simplest peptides in this class, yet it has profound effects on gene expression, immune cell function, and cellular regeneration.
The simplicity of Vilon’s structure is one of its key strengths. As a dipeptide, it has a small molecular size (around 275 daltons), which allows it to interact efficiently with cell membranes and target specific molecules inside cells. This small size allows Vilon to penetrate cells and bind to chromatin, the DNA-protein complex that regulates gene expression. Once inside, Vilon helps unlock regions of DNA that have become silenced due to aging or environmental stress, facilitating gene reactivation and promoting regeneration.
The thymus plays a critical role in immune system function by producing T cells, which are essential for defending the body against pathogens. As we age, the thymus shrinks, leading to a decline in T-cell production and immune system function. Vilon, being derived from thymic tissue, directly influences the thymus and immune cells. By supporting T-cell differentiation and enhancing immune response, Vilon helps restore some of the youthful vigor of the immune system.
|
Peptide |
Source |
Mechanism of Action |
Key Benefits |
|
Vilon |
Thymus-derived |
Epigenetic regulation of chromatin, immune modulation |
Immune system support, cellular regeneration, anti-aging |
|
Thymalin |
Thymus-derived |
Immune system modulation, T-cell activation |
Thymic regeneration, immune response enhancement |
|
Sema |
Brain-derived |
Modulates brain plasticity and neurogenesis |
Cognitive enhancement, neuroprotection |
Vilon works primarily by interacting with chromatin, the material in the cell nucleus that contains DNA. Chromatin is tightly packed during aging, which leads to the silencing of certain genes, including those involved in DNA repair and cellular regeneration. Vilon helps “unpack” these chromatin regions, allowing the genes to become transcriptionally active again.
By promoting the expression of ribosomal genes, Vilon enhances protein synthesis, a key process for tissue repair and cell regeneration. In studies, it has been shown to increase the activity of ribosomal RNA genes, which are responsible for producing proteins necessary for cellular function.
Vilon’s ability to influence gene expression without altering the DNA sequence is an example of epigenetic regulation. Epigenetic changes refer to modifications that affect gene activity without changing the underlying genetic code. Vilon acts as an epigenetic modulator by binding to specific regions of DNA and chromatin, promoting a more open and active chromatin state. This decondensation of chromatin allows previously silenced genes to become active again, facilitating cellular repair and regeneration.
One of the primary benefits of Vilon peptide is its ability to support thymic regeneration and T-cell activation. As we age, the thymus naturally shrinks, leading to a decline in immune function. Research has shown that Vilon can stimulate thymic function, increasing the production and differentiation of T cells. By promoting the maturation of T cells, Vilon helps improve immune responses and enhances the body’s ability to fight infections.
In animal studies, Vilon has been shown to enhance the proliferation of thymocytes, the immature T cells in the thymus. It has also increased the presence of proliferating cells in thymic lobules, which are essential for generating functional T cells.
Vilon plays a critical role in modulating immune responses, particularly in the context of aging and immune suppression. By promoting the reactivation of genes associated with immune cell function, Vilon helps restore balance in the immune system. It has been found to regulate cytokine production, reducing excessive inflammation and improving the body’s ability to respond to infections. In studies involving elderly animals, Vilon administration helped normalize immune function and reduced the signs of immunosenescence, the gradual decline in immune system function with age.
|
Immune Cell Type |
Effect of Vilon |
Key Outcome |
|
Thymocytes |
Stimulates proliferation and differentiation |
Increased production of functional T-cells |
|
Lymphocytes |
Enhances gene expression and proliferation |
Improved immune cell activation |
|
Monocytes |
Modulates inflammatory cytokine production |
Reduced inflammation and improved immune balance |
Vilon’s regenerative properties extend beyond the immune system. It has shown significant potential in promoting tissue repair and cellular regeneration. The peptide helps activate genes involved in cellular proliferation and tissue regeneration, aiding in the repair of damaged tissues. This is particularly valuable in conditions involving chronic inflammation, aging, or tissue injury, where cellular regeneration is often impaired.
In studies, Vilon has been shown to improve the function of fibroblasts, the cells responsible for producing collagen and maintaining the structural integrity of tissues. By enhancing fibroblast activity, Vilon promotes tissue repair and helps prevent the degeneration of connective tissues.
Cellular senescence, the state in which cells permanently stop dividing, is a hallmark of aging. Senescent cells often accumulate in tissues and secrete pro-inflammatory molecules that contribute to aging and tissue dysfunction. Vilon helps delay or even reverse cellular senescence by reactivating genes that are typically silenced with age. In studies of fibroblasts and immune cells, Vilon has been shown to reduce markers of cellular senescence, promoting healthier, more youthful cell behavior.
Vilon’s ability to reactivate silenced genes and promote cellular regeneration makes it an effective anti-aging compound. In animal studies, Vilon has been shown to extend lifespan and improve the overall health of aging individuals. The peptide helps restore normal cellular function and reduces the damaging effects of oxidative stress and inflammation, both of which are associated with aging. By supporting the body’s natural regenerative processes, Vilon helps slow the progression of age-related decline in immune function, tissue repair, and cellular regeneration. This results in enhanced longevity and improved quality of life as we age.
Vilon’s regenerative properties contribute to improved physical resilience and recovery. By enhancing tissue repair and promoting cellular regeneration, Vilon helps the body recover more quickly from stress, injury, or illness. This is particularly beneficial for individuals recovering from surgery, trauma, or chronic inflammatory conditions. Its ability to support faster healing times and boost tissue regeneration can help individuals regain strength and function more effectively, improving overall physical performance and resilience. The peptide aids the body’s natural healing mechanisms, leading to quicker recovery and less risk of long-term damage.
Vilon enhances immune resilience by promoting T-cell differentiation and improving immune cell function. This is especially important for aging individuals, whose immune systems often become less efficient over time. Vilon helps support immune cell activity by reactivating essential genes and regulating cytokine production. By reducing inflammation, it helps prevent chronic inflammatory responses that can weaken the immune system. As a result, Vilon plays a key role in maintaining a robust immune system, making the body more resilient to infections and illnesses. This is particularly valuable in supporting immune health as we age, ensuring that the body remains protected against pathogens and other threats.
|
Benefit Area |
Vilon’s Effect on Aging |
Evidence/Outcome |
|
Cellular Regeneration |
Promotes tissue repair, enhances cell regeneration |
Increased fibroblast activity, collagen synthesis |
|
Anti-Inflammatory |
Reduces chronic inflammation associated with aging |
Lower levels of TNF-α, IL-6 cytokines in aging models |
|
Lifespan Extension |
Potential to extend lifespan by improving tissue function and immune response |
Animal studies show increased lifespan and improved health |
Preclinical research has highlighted the promising effects of Vilon in animal models. Studies have shown that Vilon enhances immune function, promotes tissue regeneration, and supports overall cellular health. For instance, in aging animal models, Vilon administration has led to significant improvements in thymic function, boosting T-cell production. This rejuvenation of the immune system suggests that Vilon could play a vital role in addressing age-related immune dysfunction, ultimately promoting healthier aging and improving immune resilience.
In vitro research has also shed light on how Vilon affects immune cells at the cellular level. Studies have demonstrated that Vilon can enhance the proliferative capacity of lymphocytes, improving their response to both stress and injury. Through its ability to modulate gene expression and promote chromatin decondensation, Vilon helps restore the youthful behavior of immune cells. This mechanism is critical for bolstering the immune system’s ability to fight infections, balance immune responses, and support overall cellular integrity.
Vilon peptide offers a powerful solution for cellular regeneration and immune system support. By enhancing immune cell differentiation and promoting tissue repair, it provides significant benefits, particularly for aging individuals and those with weakened immune systems. As research progresses, Vilon’s potential to revolutionize regenerative medicine becomes clearer, helping to extend health span and improve recovery.
At Peplyte, we provide high-quality products designed to support optimal immune function and promote longevity, offering valuable tools for overall well-being.
A: Vilon peptide is a bioregulator derived from thymic tissue. It promotes immune cell differentiation and enhances tissue repair, supporting cellular regeneration and immune system function.
A: Vilon peptide enhances immune cell function by stimulating T-cell differentiation and regulating cytokine production, improving the body’s immune response.
A: Vilon peptide helps combat aging by promoting tissue regeneration, boosting immune function, and supporting cellular health, leading to improved recovery and longevity.
A: Yes, Vilon peptide supports cellular regeneration by enhancing protein synthesis and activating key genes involved in tissue repair, making it beneficial for aging and damaged cells.
